Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal

Clinical Genetics

Volumn 85, Issue 1, 2014, Pages 31-35

  Ghadirian, P ^a   Robidoux, A ^a   Nassif, E ^a   Martin, G ^a   Potvin, C ^a   Patocskai, E ^a   Younan, R ^a   Larouche, N ^a   Venne, A ^a   Zhang, S ^b   Royer, R ^b   Narod, S A ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA1; BRCA2; Breast cancer; DCIS; French Canadian; Prevalence

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER CENTER; CANCER PATIENT; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SECOND DEGREE RELATIVE; TUMOR INVASION;

BRCA1; BRCA2; BREAST CANCER; DCIS; FRENCH-CANADIAN; PREVALENCE;

ADULT; AGED; AMBULATORY CARE FACILITIES; BREAST NEOPLASMS; CANADA; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; MUTATION RATE; PREVALENCE; RECEPTORS, ESTROGEN;

EID: 84890175801     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12174     Document Type: Article

References (16)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian cancer statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
2. Antoniou A, Pharoah PDP, Narod S et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003: 72 (5): 1117-1130.
3. Lubinski J, Huzarski T, Byrski T et al. The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer 2012: 131 (1): 229-234.
4. Ghadirian P, Robidoux A, Zhang P et al. The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Clin Genet 2009: 76 (5): 421-426.
5. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001: 29 (17): E88-E.
6. Malone KE, Daling JR, Doody DR et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 2006: 66: 8297-8308.
7. Górski B, Jakubowska A, Huzarski T et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004: 10 (110): 683-686.
8. Metcalfe KA, Poll A, Royer R et al. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 2010: 28 (3): 387-391.
9. Donenberg T, Lunn J, Curling D et al. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 2011: 125 (2): 591-596.
10. Thorlacius S, Olafsdottir G, Tryggvadottir L et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996: 13: 117-119.
11. Kwong A, Ng EK, Wong CL et al. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS One 2012: 7 (9): e43994.
12. Tonin PM, Mes-Mason A-M, Futreal PA et al. Founder BRCA1 and BRCA2 mutations in French-Canadian breast and ovarian cancer families. Am J Hum Genet 1998: 63 (5): 1341-1351.
13. Simard J, Dumont M, Moisan A-M et al. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multi-step testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet 2007: 44 (2): 107-121.
14. Cavallone L, Arcand SL, Maugard CM et al. Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer. Fam Cancer 2010: 9: 507-517.
15. Moisan AM, Fortin J, Dumont M et al. No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 2006: 10 (2): 104-115.
16. Hall MJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In situ and referred for genetic testing. Cancer Prev Res (Phila) 2010: 3 (12): 1579-1585.